483 Intas Pharmaceuticals Jul 2017

483 Intas Pharmaceuticals Jul 2017

Steven Donald FDA$119.00 - Available Now

FDA investigators audited the Intas Pharmaceuticals - Ahmedabad, India facility and issued inspectional observations (via FDA 483) on 31 Jul 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 31 Jul 2017
  • Location: Ahmedabad, India
  • FEI: 3003157498
Add To Cart